Back to Screener

Healthcare

MatsukiyoCocokara & Co.(MSMKF)

Live Price

Offline

$14.60

+0.00% today

1Y Change

-19.36%

Window

Jun 30, 2025 โ†’ Jun 24, 2026

Market Cap
$922.59B
Revenue Growth
+3.8%
EPS Growth
+6.8%
Dividend Yield
2.1%

Coverage: 253 bars ยท Jun 30, 2025 โ†’ Jun 24, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

MatsukiyoCocokara & Co. (MSMKF) is a Healthcare stock with a market cap of $922.59B and listed on OTC. The stock last traded around $14.60 and down 19.4% across the available one-year price window (Jun 30, 2025 โ†’ Jun 24, 2026). Baseline metrics include revenue growth of +3.8%, EPS growth of +6.8%, a dividend yield of 2.1%. What stands out right now is revenue +3.8%, EPS +6.8%, free cash flow +54.4% with operating margin 7.7% and ROIC 9.8%. The dividend is present but secondary, with a yield around 2.1%. Valuation is more restrained than many high-expectation growth names at P/E 16.5 and price/sales 0.8. Stock Foundry combines MSMKF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

MSMKF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

Relative Read

MSMKF trails SPY

MSMKF is 38.04 pts behind over the shared 1Y window.

MSMKF had 27.18 pts deeper max drawdown than SPY.

MSMKF beat SPY in 0 of 2 calendar years shown and trailed in 2.

MSMKF

-19.36%

Normalized return

SPY

+18.68%

S&P 500

Excess Return

-38.04 pts

Relative to SPY

MSMKF Max Drawdown

-36.31%

Trailing 1Y

SPY Max Drawdown

-9.13%

Trailing 1Y

MSMKFSPY

Calendar-Year Returns

Uses the longest available daily history for MSMKF and SPY.

YearMSMKFSPYExcessLeader
2026-19.65%+6.71%-26.35 ptsSPY
2025+0.36%+11.19%-10.83 ptsSPY

Earnings Reports

๐Ÿ“… Last reportedJun 3, 2026Q2
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
Q2
Jun 3, 26
โœ“
0.91
Est 0.87
+4.6%
โ€”
Est โ€”
โ€”
Jun 3
Q1
Jan 27, 26
โœ“
2.38
Est 2.20
+8.2%
โ€”
Est โ€”
โ€”
Jan 27
Q1
Jan 17, 26
โœ—
0.34
Est 0.38
-10.5%
โ€”
Est โ€”
โ€”
Jan 17
Q1
Feb 13, 23
97.80
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Feb 13
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.